Russian drugmaker Pharmasyntez and China's Hualan Bio will join forces on the development of new drugs and technology ...

The Russian government plans to double the volume of localized active pharmaceutical ingredients (APIs) within the next five ...

French biopharma Ipsen (Euronext: IPN) has reported a strong third quarter, with total revenue rising 9% to 915 million euros ...

In Europe, the European Medicines Agency (EMA) was active this week with its Committee for Medicinal Products for Human Use ...

Boston, USA-based neuroscience company Newleos Therapeutics has appointed Timothy Noyes as president and chief executive (CEO).

Oncolytic immunotherapies specialist Replimune Group has announced that the US Food and Drug Administration (FDA) has ...

US trade group the Research and Manufacturers of America (PhRMA) has hailed the impact of direct purchase programs (DPPs), ...

South Korea-based Samsung Bioepis and Chinese biotech start-up Phrontline Biopharma have entered into a global collaboration ...

Following an extensive review, Belgian biotech Galapagos today revealed its intention to wind down its cell therapy business ...

California, USA-based Alto Neuroscience saw its shares shoot up more than 80% to $11.00 yesterday, after it revealed it has ...

German Merck KGaA’s recently acquired subsidiary SpringWorks Therapeutics today announced that long-term efficacy and safety data from the Phase III DeFi trial of Ogsiveo (nirogacestat) were in the ...

South Korea’s SK Biopharmaceuticals (KRX: 326030) has partnered with Brazil’s Eurofarma to launch Mentis Care, a ...